ARCHIVES

In Congress: Senate Committee Approves 15% Increase For NCI In FY 1999; Report Urges NCI To Increase Research In Several Cancers

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

NCAB to Review Coding of Projects Addressing Minorites and Undeserved

February 19, 1999

On Capitol Hill: HCFA Closes Comment Period On Proposal For prospective Payment System That Cancer Groups oppose

September 17, 1999

In Brief: HHS Implements Debarment Regulations; Joftes, Cain Head New NCI contract, Grants Branches

October 24, 1980

NCI-Approved Clinical Trials

July 28, 2006

FDA Hazleton Probe Finds Some Problems; Results Unaffected

April 23, 1976